Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Esophageal Cancer Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Esophageal Cancer Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Fluorouracil 1.4.3 Cisplatin 1.4.4 Docetaxel 1.4.5 Carboplatin 1.4.6 Others 1.5 Market by Application 1.5.1 Global Esophageal Cancer Drugs Market Share by Application: 2020 VS 2026 1.5.2 Targeted Therapy 1.5.3 Chemotherapy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Esophageal Cancer Drugs Market Perspective (2015-2026) 2.2 Esophageal Cancer Drugs Growth Trends by Regions 2.2.1 Esophageal Cancer Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Esophageal Cancer Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Esophageal Cancer Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Esophageal Cancer Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Esophageal Cancer Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Esophageal Cancer Drugs Players by Market Size 3.1.1 Global Top Esophageal Cancer Drugs Players by Revenue (2015-2020) 3.1.2 Global Esophageal Cancer Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Esophageal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Esophageal Cancer Drugs Market Concentration Ratio 3.2.1 Global Esophageal Cancer Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Esophageal Cancer Drugs Revenue in 2019 3.3 Esophageal Cancer Drugs Key Players Head office and Area Served 3.4 Key Players Esophageal Cancer Drugs Product Solution and Service 3.5 Date of Enter into Esophageal Cancer Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Esophageal Cancer Drugs Historic Market Size by Type (2015-2020) 4.2 Global Esophageal Cancer Drugs Forecasted Market Size by Type (2021-2026) 5 Esophageal Cancer Drugs Breakdown Data by Application (2015-2026) 5.1 Global Esophageal Cancer Drugs Market Size by Application (2015-2020) 5.2 Global Esophageal Cancer Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Esophageal Cancer Drugs Market Size (2015-2020) 6.2 Esophageal Cancer Drugs Key Players in North America (2019-2020) 6.3 North America Esophageal Cancer Drugs Market Size by Type (2015-2020) 6.4 North America Esophageal Cancer Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Esophageal Cancer Drugs Market Size (2015-2020) 7.2 Esophageal Cancer Drugs Key Players in Europe (2019-2020) 7.3 Europe Esophageal Cancer Drugs Market Size by Type (2015-2020) 7.4 Europe Esophageal Cancer Drugs Market Size by Application (2015-2020) 8 China 8.1 China Esophageal Cancer Drugs Market Size (2015-2020) 8.2 Esophageal Cancer Drugs Key Players in China (2019-2020) 8.3 China Esophageal Cancer Drugs Market Size by Type (2015-2020) 8.4 China Esophageal Cancer Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Esophageal Cancer Drugs Market Size (2015-2020) 9.2 Esophageal Cancer Drugs Key Players in Japan (2019-2020) 9.3 Japan Esophageal Cancer Drugs Market Size by Type (2015-2020) 9.4 Japan Esophageal Cancer Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Esophageal Cancer Drugs Market Size (2015-2020) 10.2 Esophageal Cancer Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Esophageal Cancer Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Esophageal Cancer Drugs Market Size by Application (2015-2020) 11 India 11.1 India Esophageal Cancer Drugs Market Size (2015-2020) 11.2 Esophageal Cancer Drugs Key Players in India (2019-2020) 11.3 India Esophageal Cancer Drugs Market Size by Type (2015-2020) 11.4 India Esophageal Cancer Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Esophageal Cancer Drugs Market Size (2015-2020) 12.2 Esophageal Cancer Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Esophageal Cancer Drugs Market Size by Type (2015-2020) 12.4 Central & South America Esophageal Cancer Drugs Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Bristol-Myers Squibb Company 13.1.1 Bristol-Myers Squibb Company Company Details 13.1.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue 13.1.3 Bristol-Myers Squibb Company Esophageal Cancer Drugs Introduction 13.1.4 Bristol-Myers Squibb Company Revenue in Esophageal Cancer Drugs Business (2015-2020)) 13.1.5 Bristol-Myers Squibb Company Recent Development 13.2 Eli Lilly and Company 13.2.1 Eli Lilly and Company Company Details 13.2.2 Eli Lilly and Company Business Overview and Its Total Revenue 13.2.3 Eli Lilly and Company Esophageal Cancer Drugs Introduction 13.2.4 Eli Lilly and Company Revenue in Esophageal Cancer Drugs Business (2015-2020) 13.2.5 Eli Lilly and Company Recent Development 13.3 F. Hoffmann-La Roche Ltd 13.3.1 F. Hoffmann-La Roche Ltd Company Details 13.3.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue 13.3.3 F. Hoffmann-La Roche Ltd Esophageal Cancer Drugs Introduction 13.3.4 F. Hoffmann-La Roche Ltd Revenue in Esophageal Cancer Drugs Business (2015-2020) 13.3.5 F. Hoffmann-La Roche Ltd Recent Development 13.4 Merck & Co., Inc. 13.4.1 Merck & Co., Inc. Company Details 13.4.2 Merck & Co., Inc. Business Overview and Its Total Revenue 13.4.3 Merck & Co., Inc. Esophageal Cancer Drugs Introduction 13.4.4 Merck & Co., Inc. Revenue in Esophageal Cancer Drugs Business (2015-2020) 13.4.5 Merck & Co., Inc. Recent Development 13.5 Sanofi 13.5.1 Sanofi Company Details 13.5.2 Sanofi Business Overview and Its Total Revenue 13.5.3 Sanofi Esophageal Cancer Drugs Introduction 13.5.4 Sanofi Revenue in Esophageal Cancer Drugs Business (2015-2020) 13.5.5 Sanofi Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Esophageal Cancer Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Esophageal Cancer Drugs Revenue Table 3. Ranking of Global Top Esophageal Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Esophageal Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Fluorouracil Table 6. Key Players of Cisplatin Table 7. Key Players of Docetaxel Table 8. Key Players of Carboplatin Table 9. Key Players of Others Table 10. Global Esophageal Cancer Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Esophageal Cancer Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Esophageal Cancer Drugs Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Esophageal Cancer Drugs Market Share by Regions (2015-2020) Table 14. Global Esophageal Cancer Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Esophageal Cancer Drugs Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Esophageal Cancer Drugs Market Growth Strategy Table 20. Main Points Interviewed from Key Esophageal Cancer Drugs Players Table 21. Global Esophageal Cancer Drugs Revenue by Players (2015-2020) (Million US$) Table 22. Global Esophageal Cancer Drugs Market Share by Players (2015-2020) Table 23. Global Top Esophageal Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esophageal Cancer Drugs as of 2019) Table 24. Global Esophageal Cancer Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Esophageal Cancer Drugs Product Solution and Service Table 27. Date of Enter into Esophageal Cancer Drugs Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$) Table 30. Global Esophageal Cancer Drugs Market Size Share by Type (2015-2020) Table 31. Global Esophageal Cancer Drugs Revenue Market Share by Type (2021-2026) Table 32. Global Esophageal Cancer Drugs Market Size Share by Application (2015-2020) Table 33. Global Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$) Table 34. Global Esophageal Cancer Drugs Market Size Share by Application (2021-2026) Table 35. North America Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$) Table 36. North America Key Players Esophageal Cancer Drugs Market Share (2019-2020) Table 37. North America Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$) Table 38. North America Esophageal Cancer Drugs Market Share by Type (2015-2020) Table 39. North America Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$) Table 40. North America Esophageal Cancer Drugs Market Share by Application (2015-2020) Table 41. Europe Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Esophageal Cancer Drugs Market Share (2019-2020) Table 43. Europe Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$) Table 44. Europe Esophageal Cancer Drugs Market Share by Type (2015-2020) Table 45. Europe Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$) Table 46. Europe Esophageal Cancer Drugs Market Share by Application (2015-2020) Table 47. China Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$) Table 48. China Key Players Esophageal Cancer Drugs Market Share (2019-2020) Table 49. China Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$) Table 50. China Esophageal Cancer Drugs Market Share by Type (2015-2020) Table 51. China Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$) Table 52. China Esophageal Cancer Drugs Market Share by Application (2015-2020) Table 53. Japan Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Esophageal Cancer Drugs Market Share (2019-2020) Table 55. Japan Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$) Table 56. Japan Esophageal Cancer Drugs Market Share by Type (2015-2020) Table 57. Japan Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$) Table 58. Japan Esophageal Cancer Drugs Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Esophageal Cancer Drugs Market Share (2019-2020) Table 61. Southeast Asia Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Esophageal Cancer Drugs Market Share by Type (2015-2020) Table 63. Southeast Asia Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Esophageal Cancer Drugs Market Share by Application (2015-2020) Table 65. India Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$) Table 66. India Key Players Esophageal Cancer Drugs Market Share (2019-2020) Table 67. India Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$) Table 68. India Esophageal Cancer Drugs Market Share by Type (2015-2020) Table 69. India Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$) Table 70. India Esophageal Cancer Drugs Market Share by Application (2015-2020) Table 71. Central & South America Key Players Esophageal Cancer Drugs Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Esophageal Cancer Drugs Market Share (2019-2020) Table 73. Central & South America Esophageal Cancer Drugs Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Esophageal Cancer Drugs Market Share by Type (2015-2020) Table 75. Central & South America Esophageal Cancer Drugs Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Esophageal Cancer Drugs Market Share by Application (2015-2020) Table 77. Bristol-Myers Squibb Company Company Details Table 78. Bristol-Myers Squibb Company Business Overview Table 79. Bristol-Myers Squibb Company Product Table 80. Bristol-Myers Squibb Company Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$) Table 81. Bristol-Myers Squibb Company Recent Development Table 82. Eli Lilly and Company Company Details Table 83. Eli Lilly and Company Business Overview Table 84. Eli Lilly and Company Product Table 85. Eli Lilly and Company Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$) Table 86. Eli Lilly and Company Recent Development Table 87. F. Hoffmann-La Roche Ltd Company Details Table 88. F. Hoffmann-La Roche Ltd Business Overview Table 89. F. Hoffmann-La Roche Ltd Product Table 90. F. Hoffmann-La Roche Ltd Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$) Table 91. F. Hoffmann-La Roche Ltd Recent Development Table 92. Merck & Co., Inc. Company Details Table 93. Merck & Co., Inc. Business Overview Table 94. Merck & Co., Inc. Product Table 95. Merck & Co., Inc. Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$) Table 96. Merck & Co., Inc. Recent Development Table 97. Sanofi Company Details Table 98. Sanofi Business Overview Table 99. Sanofi Product Table 100. Sanofi Revenue in Esophageal Cancer Drugs Business (2015-2020) (Million US$) Table 101. Sanofi Recent Development Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Esophageal Cancer Drugs Market Share by Type: 2020 VS 2026 Figure 2. Fluorouracil Features Figure 3. Cisplatin Features Figure 4. Docetaxel Features Figure 5. Carboplatin Features Figure 6. Others Features Figure 7. Global Esophageal Cancer Drugs Market Share by Application: 2020 VS 2026 Figure 8. Targeted Therapy Case Studies Figure 9. Chemotherapy Case Studies Figure 10. Esophageal Cancer Drugs Report Years Considered Figure 11. Global Esophageal Cancer Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Esophageal Cancer Drugs Market Share by Regions: 2020 VS 2026 Figure 13. Global Esophageal Cancer Drugs Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Esophageal Cancer Drugs Market Share by Players in 2019 Figure 16. Global Top Esophageal Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esophageal Cancer Drugs as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Esophageal Cancer Drugs Revenue in 2019 Figure 18. North America Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Esophageal Cancer Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Bristol-Myers Squibb Company Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020) Figure 27. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Eli Lilly and Company Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020) Figure 29. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020) Figure 31. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Merck & Co., Inc. Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020) Figure 33. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Sanofi Revenue Growth Rate in Esophageal Cancer Drugs Business (2015-2020) Figure 35. Bottom-up and Top-down Approaches for This Report Figure 36. Data Triangulation Figure 37. Key Executives Interviewed

Bristol-Myers Squibb Company Eli Lilly and Company F. Hoffmann-La Roche Ltd Merck & Co., Inc. Sanofi